Nippon India Pharma Fund vs UTI Healthcare Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
UTI Healthcare Fund - Regular Plan - Growth Option
Chart Comparison
Overview
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹8114 Cr | ₹1097 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹500 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 05 Jun 2004 | 30 Jul 2005 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare | BSE Healthcare |
| Turn Over | 21% | 28% |
| Expense Ratio | 1.82 | 2.22 |
| Manager | Sailesh Raj Bhan | Kamal Gada |
| ISIN Code | INF204K01968 | INF789F01695 |
| Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | UTI Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 1 Month | 2.16% | 1.24% |
| 6 Month | 3.03% | 7.65% |
| 1 Year | -0.53% | 2% |
| 3 Year | 20.87% | 23.73% |
| 5 Year | 18.19% | 17.94% |
SIP Return Analysis
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 6 Month | -1.61% | 0.24% |
| 1 Year | 1.06% | 6.15% |
| 3 Year | 16.73% | 21.63% |
| 5 Year | 15.96% | 18.37% |
Rolling Lumpsum Returns
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 1 Year | 16.99% | 11.94% |
| 3 Year | 20.8% | 16.4% |
| 5 Year | 20.54% | 14.62% |
Risk Management
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Standard Deviation | 15.24% | 15.78% |
| Sharp | 0.90% | 1.03% |
| Beta | 0.91% | 0.95% |
| Alpha | -0.55% | 1.30% |
Fund Managers
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Name | Sailesh Raj Bhan | Kamal Gada |
| Total AUM | ₹96086 Cr | ₹870 Cr |
| Funds Managed | 5 | 1 |
| Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
Market Cap
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Others | 1.52 | 4.01 |
| Large Cap | 33.27 | 22.4 |
| Mid Cap | 33.86 | 33.54 |
| Small Cap | 31.35 | 40.04 |
Sector Allocation
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Others | 0.53 | 1.02 |
| Healthcare | 99.47 | 97.9 |
| Basic Materials | - | 1.07 |
Top Comparisons
UTI Corporate Bond Fund - Regular Plan - Growth Option
3Y Returns7.71%
Sundaram Corporate Bond Fund Regular Plan- Growth
3Y Returns7.46%
ICICI Prudential Multi-Asset Fund - Growth
3Y Returns19.59%
Nippon India Multi Asset Allocation Fund - Regular Plan - Growth Option
3Y Returns20.28%
Aditya Birla Sun Life Savings Fund-Retail Growth
3Y Returns7.51%
Mirae Asset Ultra Short Duration Fund Regular Growth
3Y Returns7.36%
INVESCO INDIA ESG INTEGRATION STRATEGY FUND REGULAR GROWTH
3Y Returns13.28%
Tata Ethical Fund-Regular Plan - Growth Option
3Y Returns10.92%